BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

SurgiQuest Receives FDA Clearance to Market the World's First Elastomeric Single Incision Laparoscopy Kit


5/20/2010 8:11:45 AM

ORANGE, Conn., May 20 /PRNewswire/ -- SurgiQuest, Inc., announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") to market the Company's new line of advanced 5mm AnchorPort® Trocars indicated for use as a Single Incision Laparoscopy Kit (SILK).

SurgiQuest pioneered the world's first and only trocar with an integrated elastomeric, stretchable cannula system that goes in elongated and self adjusts to accommodate the patient' abdominal wall thickness. Because the elastomeric cannulas have a softer outer skin it is gentler on tissue thereby minimizing tissue trauma.

The AnchorPort® Cannula's distal tip softly anchors in place within the abdominal cavity and does not pull out prematurely like rigid, fixed-length conventional trocars from other manufacturers. Conventional rigid and fixed length trocars protrude into the abdominal cavity which can cause crisscross hand instrument "sword fighting" which severely limits operating maneuverability. The AnchorPort® SILK device offers surgeons unprecedented freedom of movement for increased accuracy and efficiency during single incision laparoscopic surgery.

"We believe that this is breakthrough for single incision surgery," said Mr. Kurt Azarbarzin, SurgiQuest's Founder and CEO, "Every surgeon who has used the AnchorPort® SILK device to date has told us that they prefer it because it makes the single incision procedure that much easier to perform."

AnchorPort® SILK device is the only Single Incision Laparoscopy system that offers bladeless, optical entry to provide the surgeon direct visualization of all tissue layers during abdominal entry for enhanced patient safety. During the procedure the surgeon makes a 1 inch skin incision through which three or more tiny cannula ports are placed strategically apart to provide optimal intra-abdominal access. After the procedure the patient is left with a 1-inch belly button scar that becomes essentially invisible after healing. Additionally, AnchorPort® 5mm trocars are also ideal for GYN and pediatric patients."

SurgiQuest, Inc. is a private venture-backed company, founded in May 2006. It develops, manufactures, and markets access technology for minimally invasive surgery.

www.surgiquest.com

SOURCE SurgiQuest, Inc.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->